# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001129928-21-000013
Filing Date
2021-03-05
Accepted
2021-03-05 15:03:55
Documents
114
Period of Report
2020-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 20-F | oncyf-20201231.htm iXBRL | 20-F | 2332784
2 | EX-2.1 | ex21exdescriptionofsecurit.htm | EX-2.1 | 3137
3 | EX-4.12 | ex412employmentagreementth.htm | EX-4.12 | 249329
4 | EX-4.13 | ex413mattcoffeyamendment-e.htm | EX-4.13 | 13924
5 | EX-4.14 | ex414kirklookamendment-emp.htm | EX-4.14 | 14303
6 | EX-4.15 | ex415allisonhagermanamendm.htm | EX-4.15 | 14549
7 | EX-4.16 | ex416andrewdeguttadauroame.htm | EX-4.16 | 13596
8 | EX-4.17 | ex417thomasheinemanamendme.htm | EX-4.17 | 13627
9 | EX-8.0 | ex80subsidiaries2020.htm | EX-8.0 | 3615
10 | EX-12.1 | ex121ceocertification2020.htm | EX-12.1 | 9904
11 | EX-12.2 | ex122cfocertification2020.htm | EX-12.2 | 9616
12 | EX-13.1 | ex131ceocertification2020.htm | EX-13.1 | 5139
13 | EX-13.2 | ex132cfocertification2020.htm | EX-13.2 | 4776
14 | EX-15.1 | ex151-2020mda.htm | EX-15.1 | 391485
15 | EX-15.2 | ex152ey2020consent.htm | EX-15.2 | 5928
16 |  | eyheader1.jpg | GRAPHIC | 2717
17 |  | oncolyticslogotaglineblueaa.jpg | GRAPHIC | 367326
21 |  | oncyf-20201231_g1.jpg | GRAPHIC | 148102
22 |  | oncyf-20201231_g2.jpg | GRAPHIC | 460603
23 |  | oncyf-20201231_g3.jpg | GRAPHIC | 29941
| Complete submission text file | 0001129928-21-000013.txt |  | 11973142

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
18 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | oncyf-20201231.xsd | EX-101.SCH | 78231
19 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | oncyf-20201231_cal.xml | EX-101.CAL | 74724
20 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | oncyf-20201231_def.xml | EX-101.DEF | 291317
24 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | oncyf-20201231_lab.xml | EX-101.LAB | 633375
25 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | oncyf-20201231_pre.xml | EX-101.PRE | 451812
26 | EXTRACTED XBRL INSTANCE DOCUMENT | oncyf-20201231_htm.xml | XML | 1558103

Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38512 | Film No.: 21718126
SIC: 2834 Pharmaceutical Preparations